News | Cath Lab | September 21, 2021

Medtronic Recalls Neurovascular Pipeline Flex Embolization Devices for Risk of Fractures During Placement, Retrieval or Movement of Device

The recalled brain aneurysm stents may fracture and embolized pieces can be released into near vasculature

Medtronic is recalling its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device with Shield Technology, which are transcatheter devices used to seal brain aneurysms. The company said there is a risk of the delivery system’s wire and tubes fracturing and breaking off when the system is being used to place, retrieve, or move the stent inside a patient.

September 21, 2021 — Medtronic is recalling its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device with Shield Technology, which are transcatheter devices used to seal brain aneurysms. The company said there is a risk of the delivery system’s wire and tubes fracturing and breaking off when the system is being used to place, retrieve, or move the stent inside a patient.

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

Fractured pieces could be left inside the patient’s brain bloodstream. It is also possible that attempts to retrieve the fractured pieces may make the patient’s condition worse. The fragments can also cause other serious adverse health consequences such as continued blockage of blood vessels, stroke, and death.  

There have been 59 reported device malfunctions, 10 serious injuries, and two deaths related to this recall.

The recalled includes 8,825 devices in the United States that were distribution between April 18, 2019 to Aug. 13, 2020. 

Medtronic is the parent company of Micro Therapeutics Inc., ev3 Neurovascular, which makes the devices.

A recall letter was sent to all customers July 13, 2021, requesting them to: 
   • Stop use of any impacted product. 
   • All unused impacted products should be immediately quarantined.

Design and Function of the Pipeline Flex Embolization System

The Pipeline Flex Embolization Device and Pipeline Flex Embolization Device with Shield Technology are permanent mesh stent braided from platinum and tungsten and cobalt-chromium-nickel alloy wires. These devices are intended for the treatment of brain aneurysms that bulge or balloon out the sides of the blood vessel (wide-neck and fusiform). The Pipeline Flex Devices include a guidewire-based delivery system used to place the implant inside the patient.

Recalled Pipeline Flex Products: 

   • Pipeline Flex Embolization Device and Pipeline Flex Embolization Device with Shield Technology. 
   • Pipeline Flex Embolization Device Models Numbers: PED-250-XX, PED-275-XX, PED-300-XX, PED-325-XX, PED-350-XX, PED-375-XX, PED-400-XX, PED-425-XX, PED-450-XX, PED-475-XX, PED-500-XX.
   • Pipeline Flex Embolization Device with Shield Technology: PED2-250-XX, PED2-275-XX, PED2-300-XX, PED2-325-XX, PED2-350-XX, PED2-375-XX, PED2-400-XX, PED2-425-XX, PED2-450-XX, PED2-475-XX, PED2-500-XX

How to Return Recalled Products

The Vendor is asking for the return of all impacted products to Medtronic. Facilities can contact their Medtronic representative for help with product returns or to identify a suitable replacement product if one is needed. 
Complete and return the customer response form via fax to Medtronic at 1-651- 367-7075, Attention: Neurovascular Quality or email it to [email protected] 

Medtronic Contact Information 

Customers with questions about this recall can contact the recalling Medtronic’s Quality Assurance via email at [email protected] or by calling 1(800) 633-8766 (U.S. toll free). 

Additional Information on the Pipeline Flex Recall: 

   • FDA Recall announcement 
   • Pipeline Flex Medical Device Recall Database Entry
   • Pipeline Flex with Shield Technology Medical Device Recall Database Entry 

To report an issue with these devices, people can use the FDA adverse event reporting system.

 

Related Content

News | Cath Lab

October 6, 2021 — Boston Scientific Corp. announced it entered into a definitive agreement to acquire Baylis Medical ...

Home October 06, 2021
Home
Feature | Cath Lab | By Aaron Detate and Lars Thording

In the electrophysiology (EP) lab, hundreds of thousands of used devices are sent to reprocessors every year to get ...

Home September 14, 2021
Home
News | Cath Lab

July 22, 2021 — Medis Medical Imaging is partnering with CORRIB Core Lab and Sinomed in randomized clinical trial of ...

Home July 22, 2021
Home
News | Cath Lab

July 13, 2021 — East End Medical announced it received U.S. Food and Drug Administration (FDA) clearance for the company ...

Home July 14, 2021
Home
Feature | Cath Lab | By Dave Fornell, Editor

There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal ...

Home May 14, 2021
Home
News | Cath Lab

May 12, 2021 — Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has ...

Home May 12, 2021
Home
Feature | Cath Lab | By Dave Fornell, Editor

April 29, 2021 — Here is the list of late-breaking study presentations and links to articles about each of them from the ...

Home May 06, 2021
Home
Videos | Cath Lab

Ashwin Nathan M.D., a cardiology fellow in the division of Cardiovascular Medicine at the Hospital of the University of ...

Home May 05, 2021
Home
News | Cath Lab

May 3, 2021 – Results from a new study find a broad range of patients who typically undergo revascularization for stable ...

Home May 03, 2021
Home
News | Cath Lab

April 29, 2021 – A retrospective analysis of risk factors for coronary artery disease (CAD) in young African American ...

Home April 29, 2021
Home
Subscribe Now